Latest News
Empowering Journeys with PanKind's Support Navigator for Pancreatic Cancer
In our ongoing dedication to supporting Australians affected by pancreatic cancer, we are thrilled to announce a pivotal addition to PanKind's team: the Support Navigator. This new resource aims to provide navigation assistance throughout the challenging journey of pancreatic cancer.
Read story ➞
Breakthrough in Pancreatic Cancer Detection: Unlocking Liquid Biopsy Potential
Pancreatic cancer, known for its aggressive nature and late-stage diagnosis, poses challenges in effective treatment and management. However, recent advancements in medical research may offer a glimmer of hope for early detection and improved outcomes for patients.
Read story ➞
Pancreatic Cancer Care: Promising Results of Investigational mRNA Vaccine
An investigational mRNA vaccine known as autogene cevumeran has demonstrated some potential in improving treatment outcomes for patients. The latest findings, presented at the American Association for Cancer Research (AACR) Annual Meeting 2024, shed light on the promising immune response elicited by this innovative vaccine.
Read story ➞
Pancreatic Cancer Therapy: Opdivo Shows Promise in Neoadjuvant Treatment
In an interesting advance for pancreatic cancer treatment, Bristol Myers Squibb's PD-1 inhibitor, Opdivo, has shown promising results when combined with various types of chemotherapy before surgery. A pilot study presented at American Association for Cancer Research’s (AACR) annual meeting unveiled encouraging findings that suggest improved outcomes for pancreatic cancer patients.
Read story ➞